* EZETIMIBE/SIMVASTATIN
Vitorin Drug Information
The drug, also available under the name Vytorin, is used to inhibit the absorption of cholesterol consumed with food and reduce the amount of cholesterol which the body produces naturally. Therapy with such lipid-altering agents like Vitorin is included in multiple risk factor intervention, when there is no or inadequate response to a diet including restriction of saturated fats and cholesterol rich foods.
Vitorin Drug Dosage
The daily recommended dosage is 10/10 mg up to 10/80 mg, consumed once, in the evening. The initial dose is 10/20 mg. In patients requiring less aggressive LDL-C reductions it can be 10/10 mg per day. In patients that require a larger (over 55 percent) LDL-C reduction, the initial dose is 10/40 mg. After 2 weeks or so, the dosage may be adjusted if necessary. For patients with homozygous familial hypercholesterolemia the dosage is 10/40 mg or 10/80 mg. Cheap Vitorin is available in the following dosages: 10/10 mg, 10/20mg, 10/40 mg, 10/80 mg. Patients can obtain the drug from North Meds as a generic drug sold in dosages of 10/10 mg, 10/20 mg, 10/40 mg, 10/80 mg. The company also offers it as a brand medication in the same dosages. Discount Vitorin is available from the company when customers buy Vitorin in assorted quantities.
Side Effects and Precautions for Vitorin
Common side effects of Ezetimibe/Simvastatin include headache, nausea, vomiting, diarrhea. It can increase myopathy risk, so patients should report immediately any muscle pain or weakness. It should not be used concomitantly with certain CYP3A4 inhibitors or with gemfibrozil, or other lipid-lowering drugs, cyclosporine, amiodarone, danazol, diltiazem, verapamil. Ezetimibe/Simvastatin should be administered with caution in patients consuming large amounts of alcohol, or moderate or severe hepatic impairment patients. It should not be administered to pregnant women and is contraindicated in active liver diseases.
* All trademarks and registered trademarks are the property of their respective owners.

